Last Price
0.507
Today's Change
-0.012 (2.30%)
Day's Change
0.481 - 0.52
Trading Volume
35,647
Overview
Market Cap
4 Million
Shares Outstanding
8 Million
Avg Volume
1,156,737
Avg Price (50 Days)
0.52
Avg Price (200 Days)
0.92
PE Ratio
-0.15
EPS
-3.49
Earnings Announcement
11-Nov-2024
Previous Close
0.52
Open
0.51
Day's Range
0.4811 - 0.52
Year Range
0.41 - 2.92
Trading Volume
35,647
Price Change Highlight
1 Day Change
-2.39%
5 Day Change
3.32%
1 Month Change
-9.10%
3 Month Change
-33.25%
6 Month Change
-64.02%
Ytd Change
-59.74%
1 Year Change
-77.15%
3 Year Change
-99.67%
5 Year Change
-99.96%
10 Year Change
-99.99%
Max Change
-100.00%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
NordFX Weekly Forecast
Forex and Cryptocurrency Forecast for September 09 – 13, 2024
2
CEO Morning Brief
Ultra-rich Families Set to Control US$9.5 Tril by 2030, Says Deloitte
3
CEO Morning Brief
4
CEO Morning Brief
5
CEO Morning Brief
US Trade Deficit Widens to US$78.8 Bil, Largest in Two Years
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
